The cell membrane calcium binding capacity of genetically hypertensive rats is reduced when measured in the presence of the submicromolar calcium concentrations proper of intracellular environment. The present work, performed as an ancillary study to an epidemiological survey on an entire population, aimed to investigate the existence of a similar abnormality in human hypertension. Calcium binding to the erythrocyte membrane was measured in clinically healthy normotensive (n=12) and hypertensive individuals (n=24). For this purpose, a nitration technique was used, based on the determination of "Ca bound to the erythrocyte membrane in the presence of free calcium concentrations ( 1 Previous studies have reported altered calcium metabolism in both rat and human arterial hypertension.
C alcium ions play a pivotal role in vascular smooth muscle function. 1 Previous studies have reported altered calcium metabolism in both rat and human arterial hypertension. 2 -3 In genetically hypertensive rats it has been reported that, in addition to abnormalities of extracellular calcium homeostasis, the membrane calcium binding capacity in the presence of calcium concentra-tions characteristic of intracellular environment is reduced in several cell types including smooth muscle and red blood cells. 4 - 8 The possible existence in human hypertension of a similar abnormality has been hypothesized. 9 In the present study, by using free calcium concentrations comparable with those of the intracellular fluid, we measured the calcium binding capacity of the erythrocyte membrane in three groups: healthy untreated normotensive, never-treated hypertensive, and treated hypertensive individuals.
Subjects and Methods
This work was performed as an ancillary part of the Gubbio Study, 10 which is an epidemiological study on hypertension that was carried out in the population of Gubbio, a town of central Italy.
Erythrocyte membrane calcium binding was determined in a sample of study participants who were examined during the last 6 months of the cross- sectional phase of the Gubbio study, and who met the following criteria: age 30-60 years, absence of any acute or chronic diseases with the exception of arterial hypertension, and normal values for routine urine and blood laboratory measurements. Blood pressure was measured by trained medical doctors with mercury sphygmomanometers and cuffs of appropriate size. Three consecutive determinations of arterial pressure and heart rate were performed in the sitting position, the first one at least 5 minutes after application of the cuff. The average of the second and third measurements was used for the analysis. Participants were asked to refrain from eating for at least 2 hours before the visit, and from smoking and strenuous exercise for one half hour before the visit. Smoking habit was assessed by a questionnaire; information was also collected on family history of hypertension and pharmacological or dietetic treatment status. A first-void morning urine sample was obtained as a part of the electrolyte evaluation.
Persons eligible for the analysis were divided into three groups. The untreated hypertensive group included all the never-treated, clinically healthy individuals screened in the indicated period whose blood pressure was equal to or greater than 140 mm Hg systolic or 90 mm Hg diastolic. The normotensive group consisted of never-treated healthy persons with systolic and diastolic pressures equal to or lower than 139 and 89 mm Hg, respectively. They were selected on the basis of sex, age, and body mass index to match the untreated hypertensive group.
11
- 12 The treated hypertensive group consisted of clinically healthy patients, regardless of current blood pressure level, who were receiving chronic pharmacological antihypertensive treatment.
From each participant a venous heparinized blood sample was obtained with minimal stasis, and an erythrocyte membrane homogenate was prepared according to a previously described method. 13 The presence of rightside-out or inside-out vesicles was controlled in each preparation. 13 The red blood cell membrane homogenate was divided into three aliquots and calcium binding to the erythrocyte membrane was measured in vitro in each aliquot by filtration technique based on determination of the 45 Ca that associated to the membrane. 7 The mean of the three values was used to characterize each individual. Each aliquot was analyzed separately in the presence of both the 40 nmol/1 and the 1 yu.mol/1 free calcium concentrations, fixed in vitro by Ca-EGTA/EGTA buffer. 14 The technical error of these procedures was evaluated by measurement of calcium binding in split samples of red blood cell samples from a group of 35 unselected individuals surveyed during the same period in the Gubbio Study. The laboratory was totally blinded for the clinical variables and split samples.
Statistical evaluation of the data was performed by two-tailed Student's t test for unpaired observations and simple linear regression analysis.
Results
Under our experimental conditions and in agreement with previous observations, 15 calcium binding to erythrocyte membranes reached the equilibrium within 1 minute at 25° C, and it remained constant up to 60 minutes at both calcium concentrations used in the study. The binding to erythrocyte ghosts was rapidly (3 minutes) reversible by lowering the free calcium concentration with the addition of an excess of EGTA, but it was not affected by the calcium ionophore A 23187 (1 (imoVl).
Rightside-out or inside-out vesicles were never detected in the membrane homogenate prepared for calcium binding studies from red blood cell samples of participants in the Gubbio Study.
The evaluation of the intra-assay variability, performed on split red blood cell samples of 35 persons, yielded an absolute technical error of 0.26 nmol calcium/mg membrane protein at the 40 nmol concentration (24.1% of the mean calcium binding capacity observed in the paired samples); at the 1 f concentration the technical error was 0.50 nmol calcium/mg membrane protein (16.8% of the mean). Table 1 shows that the matching between the normotensive and untreated hypertensive groups from the Gubbio Study was successful; no significant difference was detectable in the means or distributions of any variable, with the obvious exception of blood pressure and antihypertensive treatment. The treated hypertensive group was older and had a slightly different sex distribution. Figure 1 shows the mean values of membrane calcium binding in the three groups. In the presence of the two calcium concentrations, we found that calcium binding capacity was, on the average, significantly reduced in untreated hypertensive as compared with normotensive individuals. Treated and untreated hypertensive persons had the same membrane calcium binding capacity at both calcium concentrations. At the 40 nmol/1 concentration, the difference between the control and treated hypertensive groups reached statistical significance. At the 1 jtmol/1 concentration, membrane bound calcium in the treated hypertensive group was lower, but not significantly, than that observed in the normotensive group.
The calcium binding capacity observed at the 40 nmol/1 concentration was positively and significantly associated with that found at the 1 /unol/1 concentration in both the treated (r=0.73,/?<0.01) and untreated (r=0.75, p<0.01) hypertensive groups. In the normotensive group this association, although detectable, did not reach statistical significance (r=0.51).
Discussion
Reduced calcium binding to the cell membrane has been described in two models of rat genetic arterial hypertension, 4 -9 although it is not detectable in secondary forms of hypertension. 9 Postnov et al 9 reported a lower membrane calcium binding in red blood cells of hypertensive patients, suggesting that this finding reflects an abnormality of the inner side of the membrane, although the free calcium concentrations used in that in vitro study were considerably higher than that physiologically present in normal erythrocytes. 17 In this study, calcium binding to erythrocyte membrane was measured in the presence of two calcium concentrations: the first concentration (40 nmol/1) is comparable with that of the normal intraerythrocytic environment 17 while the second (1 junol/1) reproduces the conditions of intracellular fluid in stimulated excitable cells. 1 Under both these experimental conditions, membranes of the nevertreated hypertensive group bound significantly less calcium than the control group. Hypertensive patients and controls came from the same population and had comparable characteristics. Data on the never-treated and treated hypertensive groups were analyzed separately. The difference versus the normotensive group was less significant for the treated than for the untreated hypertensive groups, but both groups with high blood pressure had comparable low values of membrane calcium binding. Overall, the results are in accordance with the hypothesis that membrane calcium binding capacity is reduced in hypertension. 9 The correlation found in the hypertensive groups between calcium binding values observed at two different concentrations indicates that individuals with low membrane bound calcium at 40 nmol/1 also have reduced calcium binding capacity at the 1 jimol/1 concentration. This suggests that, as previously reported in hypertensive rats, 4 -8 the reduction of membrane calcium binding capacity in hypertension is linked to a low number of binding sites rather than to an altered affinity of the membrane for calcium ions.
Membrane calcium binding could be involved in the regulation of membrane permeability 18 and of transmembrane calcium fluxes. 19 -24 If present also at the vascular level, as observed in spontaneously hypertensive rats, 6 the reduced membrane calcium binding capacity could lead to an increase of the smooth muscle cytoplasmatic calcium concentration through some of these mechanisms, and therefore, it could play some role in the maintenance of the high peripheral vascular resistance typical of hypertension. Thanks are also gratefully extended to Dr. A. Spina for her technical assistance in the preparation of the erythrocyte membranes.
